Latest Cardiovascular Disease (CVD) News
Reduced frequency of MACE for patients receiving statins, especially high-intensity statins.
Each 0.1 increase in WHR is associated with a 1.7-fold increased risk of cardiovascular death.
From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.
US veterans who underwent coronary artery bypass grafting versus percutaneous coronary intervention prior to starting dialysis had a 28% lower risk of death.
In any Diabetes Prevention Program treatment group, statin use tied to increased diabetes risk.
27% of CV deaths in diabetes patients with atherosclerotic CVD are categorized as sudden death.
Greater improvement in CHD risk factors for combined intervention versus either alone.
Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism
Exposure to androgen-deprivation therapy was associated with a nearly 2-fold increased risk of heart failure among men without pre-existing cardiovascular disease.
Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.
Overall, therapy was received by just 30.9% of those prescribed PCSK9 inhibitors.
Findings in a large study of long-term low-dose aspirin users.
The researchers found that over the study period statin use was associated with an 18% lower risk of all-cause mortality and non-significantly lower risk of CVD events and stroke.
Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction.
The results demonstrated a tendency for a decrease in LDL-C level at 24 weeks in the ANA group, and improvement was mediated through the suppression of apoB-100 synthesis.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)